XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB; TASE: XTLB.TA) has announced a binding agreement to acquire an 85% stake in NeuroNOS Ltd., a subsidiary of Beyond Air,…
January 13, 2026
As the biotechnology sector looks for high-impact clinical catalysts in 2026, Intensity Therapeutics, Inc. (NASDAQ: INTS) has positioned itself at a critical inflection point. The company…
December 04, 2025
“Vaccine Wars” Heat Up for National Influenza Vaccination Week
As we finish National Influenza Vaccination Week (Dec. 1–5, 2025), the public health message is standard: get your shot. But for investors watching the pharmaceutical…
November 14, 2025
Trinity Biotech Advances Prostate Cancer Test with New Collaboration
Trinity Biotech (NASDAQ: TRIB) has announced a strategic collaboration designed to accelerate the development of its innovative EpiCapture prostate cancer test. The partnership with a…
November 14, 2025
How ImmunityBio’s (IBRX) Revenue Growth and Narrowed Losses Could Influence Investor Sentiment
ImmunityBio Inc. (NASDAQ: IBRX),released its third-quarter and nine-month earnings earlier this month , showcasing a significant boost in revenue to $32.06 million for the quarter…